Correlation Between Century Therapeutics and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Blueprint Medicines Corp, you can compare the effects of market volatilities on Century Therapeutics and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Blueprint Medicines.
Diversification Opportunities for Century Therapeutics and Blueprint Medicines
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Century and Blueprint is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Century Therapeutics and Blueprint Medicines
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the Blueprint Medicines. In addition to that, Century Therapeutics is 1.52 times more volatile than Blueprint Medicines Corp. It trades about -0.05 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.2 per unit of volatility. If you would invest 8,277 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 1,110 from holding Blueprint Medicines Corp or generate 13.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Century Therapeutics |
| Blueprint Medicines Corp |
Century Therapeutics and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Blueprint Medicines
The main advantage of trading using opposite Century Therapeutics and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Century Therapeutics vs. Eliem Therapeutics | Century Therapeutics vs. HCW Biologics | Century Therapeutics vs. Scpharmaceuticals | Century Therapeutics vs. Milestone Pharmaceuticals |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |